Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes. J of Skin. 2022;6(6):458-462. doi:10.25251/skin.6.6.2